Regulations on Payment of Expenses for Cancer Treatment Drugs

16:14, 11/07/2024

On October 30, 2018, the Ministry of Health issued Circular 30/2018/TT-BYT to specifically regulate the payment of costs for cancer treatment drugs.

Payment of costs for cancer treatment drugs is regulated by Circular 30 as follows:

- They can only be used for cancer treatment at medical examination and treatment facilities that have cancer treatment functions (including oncology, hematology and transfusion medicine, and nuclear medicine facilities; oncology, hematology and transfusion medicine and nuclear medicine departments/units within specialized hospitals or general hospitals) and must be prescribed by a doctor who is licensed to practice with a specialized scope in oncology or hematology and transfusion medicine.

- In the case of using them to treat diseases other than cancer: The health insurance fund will pay according to the proper diagnosis and treatment guidelines of the Ministry of Health or the hospital.

- In cases where there are no diagnosis and treatment guidelines, consultation with an oncology specialist is required.

- In cases where there are no diagnosis and treatment guidelines and there is no oncology specialist, there must be a consultation chaired by the hospital leadership before prescribing use.

See details in Circular 30/2018/TT-BYT, effective from January 01, 2019.

-Thao Uyen-

>> CLICK HERE TO READ THIS ARTICLE IN VIETNAMESE

0 lượt xem

- This translation is generated by OpenAI's GPT-4o model;
- The legal regulations in this article are according to Vietnamese Law;
- This English translation is for reference purposes only and not a definitive translation of the original Vietnamese texts;
- Articles may be compiled from a variety of sources;
- Applicable Terms may have expired at the time you are reading;
- If you have any questions about the copyright of the article, please contact us via email banquyen@lawnet.vn